Lund, Sweden

Jan W Trofast

USPTO Granted Patents = 23 

 

Average Co-Inventor Count = 2.1

ph-index = 12

Forward Citations = 578(Granted Patents)


Company Filing History:


Years Active: 1987-2013

Loading Chart...
Loading Chart...
23 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Jan W. Trofast

Introduction: Jan W. Trofast, based in Lund, Sweden, is a prolific inventor known for his contributions to medical advancements. With a remarkable portfolio comprising 23 patents, he has significantly impacted the treatment of chronic respiratory conditions.

Latest Patents: Among his most notable inventions is the use of budesonide and formoterol in treating chronic obstructive pulmonary disease (COPD). His innovative work has demonstrated the effectiveness of combining these two compounds, paving the way for improved therapeutic options for patients suffering from this debilitating condition.

Career Highlights: Jan's career includes significant stints at leading pharmaceutical companies such as Astra Aktiebolag and AstraZeneca AB. His expertise and dedication to research have contributed to the development of essential medications that have improved the quality of life for many individuals.

Collaborations: Throughout his career, Jan has collaborated with esteemed colleagues including Edib Jakupovic and Bengt I. Axelsson. Their combined efforts in research and development have fostered innovative solutions in the pharmaceutical arena.

Conclusion: Jan W. Trofast stands out as a key figure in the field of pharmaceutical innovations. His enduring commitment to research and the successful application of his patents underscore his role as a vital contributor to advancements in medical treatments, particularly for chronic obstructive pulmonary disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…